Related Experiment Video
Updated: Jul 8, 2025
Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Left ventricular thrombus formation in a COVID-19 patient with a complex course of pericarditis and myocardial
Jalil Golshani1, Zahra Kalantari1, Hassan Ahangar1
1Department of Cardiology Mousavi Hospital School of Medicine Zanjan University of Medical Sciences Zanjan Iran.
Insights
Even mild coronavirus disease 2019 (COVID-19) can cause dangerous blood clots. Early screening for COVID-19 is crucial for patients with unexplained cardiac symptoms to prevent thrombotic events.
Area of Science:
- Cardiology
- Infectious Diseases
- Oncology
Background:
- Coronavirus disease 2019 (COVID-19) is a global health concern with diverse clinical manifestations.
- Thrombotic events are recognized complications of severe COVID-19, but their occurrence in mild cases is less understood.
Observation:
- A case study revealed thrombotic complications, including coronary thrombosis and left ventricular clot, in a patient with mild, nonspecific symptoms of COVID-19.
- This presentation underscores the multifaceted and sometimes unexpected nature of COVID-19's impact on the cardiovascular system.
Findings:
- COVID-19, even when presenting with nonspecific symptoms, can precipitate serious thrombotic events such as coronary thrombosis and left ventricular clots.
- The underlying mechanisms linking mild COVID-19 to thrombosis require further investigation.
Implications:
- Healthcare providers should consider COVID-19 screening for patients presenting with nonspecific cardiac symptoms, even in the absence of typical respiratory illness.
- This approach may aid in the early detection and management of potentially life-threatening thrombotic complications associated with COVID-19.
- Recognizing these atypical presentations is vital for comprehensive patient care and preventing adverse cardiovascular outcomes.
Abstract:
Our case demonstrated that thrombotic complications such as coronary thrombosis and left ventricular clot could occur even in coronavirus disease 2019 (COVID-19) patients with nonspecific symptoms which indicates the mysterious face of COVID-19. This complex process highlights the necessity of screening patients for COVID-19 disease even with nonspecific cardiac symptoms.
